57857
Lithium iodoacetate
≥97.0% (NT)
Synonym(s):
Iodoacetic acid lithium salt
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
Assay
≥97.0% (NT)
impurities
≤3% water
mp
239 °C (dec.) (lit.)
~245 °C (dec.)
SMILES string
[Li+].[O-]C(=O)CI
InChI
1S/C2H3IO2.Li/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1
InChI key
RZCFQIDTJPHHFJ-UHFFFAOYSA-M
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
Lithium iodoacetate, a halogenacetate, is a lithium salt of iodoacetate that may be used in the study of cysteine peptidases.
Caution
May discolor to yellow on storage
Other Notes
Sales restrictions may apply
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Acta crystallographica. Section B, Structural science, 55(Pt 4), 517-524 (2000-08-06)
Most halogenoacetates of alkali salts readily undergo a thermally induced polymerization reaction to poly-(hydroxyacetic acid) in the solid state. The lithium salts represent a remarkable exception. The crystal structures of lithium chloroacetate, lithium bromoacetate and lithium iodoacetate were determined ab
Experimental & molecular medicine, 43(10), 561-570 (2011-07-29)
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin
Drug delivery and translational research, 8(3), 536-542 (2018-01-03)
Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low aqueous solubility, which complicates its formulation for i.v. administration.
Journal of pharmaceutical and biomedical analysis, 123, 173-178 (2016-02-26)
In clinical practice, rifampicin exposure is estimated from its concentration in venous blood samples. In this study, we hypothesized that differences in rifampicin concentration may exist between arterial and venous plasma. An HPLC-UV method for determining rifampicin concentration in plasma
Journal of the science of food and agriculture, 91(13), 2437-2442 (2011-06-28)
Proteases have become an essential part of the modern food and feed industry, being incorporated in a large and diversified range of products for human and animal consumption. The objective of this study was to purify and characterise a protease
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service